合成及兰斯宁类似物的结构活性关系作为抗利什曼原虫药物。
Synthesis and structure-activity relationships of lansine analogues as antileishmanial agents.
机构信息
College of Pharmacy, University of Hawai'i at Hilo, Hilo, HI 96720-4029 (USA); Interdepartmental Center Biopharmanet_TEC, Universita' degli Studi di Parma, Via G. P. Usberti 27, Parma (Italy).
出版信息
ChemMedChem. 2012 Nov;7(11):1895-900. doi: 10.1002/cmdc.201200346. Epub 2012 Sep 17.
Abstract
Clear and rational thinking: A series of rationally designed, lansine-derived carbazoles was synthesized and evaluated for activity against promastigotes and amastigotes of Leishmania donovani, the causative agent of leishmaniasis. Some structural modifications gave rise to compounds with enhanced activity and selectivity over lansine, allowing structure-activity relationships to be elucidated and providing a foundation for the further development of this pharmacophore.
摘要
清晰理性的思考
我们设计并合成了一系列结构合理的源于 Lansine 的咔唑类化合物，评估其对引起利什曼病的利什曼原虫的前鞭毛体和无鞭毛体的活性。一些结构修饰使化合物的活性和选择性相对于 Lansine 增强，使我们能够阐明构效关系，并为进一步开发这一药效团提供了基础。
相似文献
1
Synthesis and structure-activity relationships of lansine analogues as antileishmanial agents.
ChemMedChem. 2012 Nov;7(11):1895-900. doi: 10.1002/cmdc.201200346. Epub 2012 Sep 17.
2
Synthesis and biological evaluation of chalcones as potential antileishmanial agents.
Eur J Med Chem. 2014 Jun 23;81:359-66. doi: 10.1016/j.ejmech.2014.05.034. Epub 2014 May 13.
3
Synthesis and biological evaluation of 4-chloro-3, 5-dinitrobenzotrifluoride analogues as antileishmanial agents.
J Med Chem. 1998 Nov 19;41(24):4885-9. doi: 10.1021/jm9804073.
4
Evaluation of synthetic substituted 1,2-dioxanes as novel agents against human leishmaniasis.
Eur J Med Chem. 2019 May 15;170:126-140. doi: 10.1016/j.ejmech.2019.02.070. Epub 2019 Mar 3.
5
3D-Quantitative structure-activity relationships of synthetic antileishmanial ring-substituted ether phospholipids.
Bioorg Med Chem. 2007 Feb 1;15(3):1252-65. doi: 10.1016/j.bmc.2006.11.018. Epub 2006 Nov 14.
6
Click inspired synthesis of antileishmanial triazolyl O-benzylquercetin glycoconjugates.
Glycoconj J. 2015 May;32(3-4):127-40. doi: 10.1007/s10719-015-9582-x. Epub 2015 Apr 14.
7
Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities.
Eur J Med Chem. 2006 Oct;41(10):1109-16. doi: 10.1016/j.ejmech.2006.03.033. Epub 2006 Sep 1.
8
Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines.
J Med Chem. 2014 Jun 26;57(12):5141-56. doi: 10.1021/jm5000408. Epub 2014 Jun 17.
9
Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.
Bioorg Med Chem Lett. 2015 Jan 15;25(2):410-3. doi: 10.1016/j.bmcl.2014.09.078. Epub 2014 Oct 2.
10
Design, Synthesis and Biological Evaluation of 7-arylbenzo[c]acridine-5,6- diones as Potential Anti-Leishmanial and anti-trypanosomal Agents.
Med Chem. 2018;14(6):563-572. doi: 10.2174/1573406414666180226163222.
引用本文的文献
1
Iodo-Cycloisomerization of Aryl(indol-3-yl)methane-Tethered Propargyl Alcohols to 3-Iodocarbazoles via Selective 1,2-Alkyl Migration.
ACS Omega. 2018 Nov 7;3(11):15024-15034. doi: 10.1021/acsomega.8b02393. eCollection 2018 Nov 30.
本文引用的文献
1
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.
J Antimicrob Chemother. 2012 Nov;67(11):2576-97. doi: 10.1093/jac/dks275. Epub 2012 Jul 24.
2
Leishmaniasis: current status of available drugs and new potential drug targets.
Asian Pac J Trop Med. 2012 Jun;5(6):485-97. doi: 10.1016/S1995-7645(12)60084-4.
3
Leishmania antimony resistance: what we know what we can learn from the field.
Parasitol Res. 2011 Nov;109(5):1225-32. doi: 10.1007/s00436-011-2555-5. Epub 2011 Jul 29.
4
1,1'-(9-Octyl-9H-carbazole-3,6-di-yl)diethanone.
Acta Crystallogr Sect E Struct Rep Online. 2010 Jul 24;66(Pt 8):o2118. doi: 10.1107/S1600536810028928.
5
Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.
Acta Trop. 2011 May;118(2):87-96. doi: 10.1016/j.actatropica.2011.02.007. Epub 2011 Mar 21.
6
Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent.
PLoS Negl Trop Dis. 2010 Sep 7;4(9):e818. doi: 10.1371/journal.pntd.0000818.
7
Synthesis, antibacterial and antifungal activities of some carbazole derivatives.
Bioorg Med Chem Lett. 2010 Mar 15;20(6):1881-4. doi: 10.1016/j.bmcl.2010.01.159. Epub 2010 Feb 4.
8
Drug resistance in visceral leishmaniasis.
J Biomed Biotechnol. 2010;2010:617521. doi: 10.1155/2010/617521. Epub 2009 Nov 1.
9
Natural product leads for drug discovery: isolation, synthesis and biological evaluation of 6-cyano-5-methoxyindolo[2,3-a]carbazole based ligands as antibacterial agents.
Bioorg Med Chem. 2009 Oct 15;17(20):7126-30. doi: 10.1016/j.bmc.2009.08.061. Epub 2009 Sep 4.
10
Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature.
Int J Infect Dis. 2010 Jun;14(6):e522-5. doi: 10.1016/j.ijid.2009.06.010. Epub 2009 Sep 1.
Zotero 插件